Total Payments
$71,774
2024 Payments
$3,148
Companies
8
Transactions
38
Medicare Patients
2,256
Medicare Billing
$237,203
Payment Breakdown by Category
Consulting$42,363 (59.0%)
Research$15,000 (20.9%)
Other$12,383 (17.3%)
Travel$1,547 (2.2%)
Food & Beverage$480.88 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $42,363 | 11 | 59.0% |
| Unspecified | $15,000 | 5 | 20.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,883 | 3 | 9.6% |
| Honoraria | $5,500 | 5 | 7.7% |
| Travel and Lodging | $1,547 | 6 | 2.2% |
| Food and Beverage | $480.88 | 8 | 0.7% |
Payments by Type
General
$56,774
33 transactions
Research
$15,000
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TRANSMEDICS, INC. | $45,000 | 14 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $19,279 | 9 | $0 (2022) |
| One Lambda, Inc. | $4,162 | 5 | $0 (2021) |
| Merck Sharp & Dohme LLC | $1,631 | 4 | $0 (2024) |
| Paragonix Technologies, Inc. | $1,500 | 1 | $0 (2024) |
| Abbott Laboratories | $113.44 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $72.24 | 3 | $0 (2022) |
| Gilead Sciences, Inc. | $17.57 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,148 | 6 | Merck Sharp & Dohme LLC ($1,631) |
| 2022 | $3,106 | 5 | TRANSMEDICS, INC. ($3,000) |
| 2021 | $40,863 | 11 | TRANSMEDICS, INC. ($27,000) |
| 2020 | $15,000 | 5 | TRANSMEDICS, INC. ($15,000) |
| 2019 | $7,157 | 8 | SANOFI-AVENTIS U.S. LLC ($6,882) |
| 2018 | $2,000 | 2 | One Lambda, Inc. ($2,000) |
| 2017 | $500.00 | 1 | One Lambda, Inc. ($500.00) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $73.54 | General |
| 10/13/2024 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| 09/29/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $264.00 | General |
| 09/23/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $542.96 | General |
| 05/16/2024 | Paragonix Technologies, Inc. | SherpaPak (Device) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: Cardiology | ||||||
| 01/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.57 | General |
| 06/05/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $20.52 | General |
| 06/05/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $20.52 | General |
| 04/28/2022 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $33.86 | General |
| 04/27/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: IMMUNOLOGY | ||||||
| 01/28/2022 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DEVICE | ||||||
| 11/12/2021 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DEVICE | ||||||
| 10/15/2021 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Consulting Fee | Cash or cash equivalent | $5,941.00 | General |
| Category: Oncology | ||||||
| 10/02/2021 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DEVICE | ||||||
| 09/27/2021 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DEVICE | ||||||
| 09/10/2021 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Consulting Fee | Cash or cash equivalent | $6,422.00 | General |
| Category: Oncology | ||||||
| 07/23/2021 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DEVICE | ||||||
| 07/12/2021 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DEVICE | ||||||
| 06/25/2021 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DEVICE | ||||||
| 04/29/2021 | One Lambda, Inc. | — | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| 04/22/2021 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: DEVICE | ||||||
| 01/21/2021 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DEVICE | ||||||
| 12/11/2020 | TRANSMEDICS, INC. | Organ Care System (Device) | — | Cash or cash equivalent | $3,000.00 | Research |
| Study: OCS Heart • Category: DEVICE | ||||||
| 11/13/2020 | TRANSMEDICS, INC. | Organ Care System (Device) | — | Cash or cash equivalent | $3,000.00 | Research |
| Study: OCS Heart • Category: DEVICE | ||||||
| 09/18/2020 | TRANSMEDICS, INC. | Organ Care System (Device) | — | Cash or cash equivalent | $3,000.00 | Research |
| Study: OCS Heart • Category: DEVICE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OCS Heart | TRANSMEDICS, INC. | $15,000 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 558 | 1,040 | $246,523 | $61,695 |
| 2022 | 9 | 534 | 943 | $229,821 | $55,578 |
| 2021 | 10 | 607 | 1,241 | $284,945 | $74,150 |
| 2020 | 8 | 557 | 948 | $188,324 | $45,780 |
Total Patients
2,256
Total Services
4,172
Medicare Billing
$237,203
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 364 | $109,785 | $25,716 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 118 | 164 | $52,832 | $12,641 | 23.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 144 | $35,051 | $9,757 | 27.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 38 | 107 | $14,492 | $4,527 | 31.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 28 | $17,544 | $4,164 | 23.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 16 | $5,601 | $1,583 | 28.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 19 | $5,720 | $1,523 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 109 | 159 | $2,638 | $1,321 | 50.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 39 | $2,860 | $463.58 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 348 | $105,603 | $24,421 | 23.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 61 | 206 | $47,376 | $12,491 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 59 | 79 | $25,277 | $5,974 | 23.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 25 | $15,984 | $4,168 | 26.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 32 | 38 | $12,209 | $2,801 | 22.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 30 | 38 | $11,551 | $2,589 | 22.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 15 | 16 | $5,480 | $1,452 | 26.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 16 | 18 | $3,900 | $1,028 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 111 | 161 | $1,449 | $476.31 | 32.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $992.00 | $178.46 | 18.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 185 | 443 | $122,694 | $31,563 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 65 | 276 | $64,516 | $17,148 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 72 | 86 | $25,178 | $6,633 | 26.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 71 | $23,879 | $6,341 | 26.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 57 | 59 | $16,782 | $4,141 | 24.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 22 | $14,328 | $3,810 | 26.6% |
About Dr. Jon Kobashigawa, M.D
Dr. Jon Kobashigawa, M.D is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467548073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Kobashigawa, M.D has received a total of $71,774 in payments from pharmaceutical and medical device companies, with $3,148 received in 2024. These payments were reported across 38 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($42,363).
As a Medicare-enrolled provider, Kobashigawa has provided services to 2,256 Medicare beneficiaries, totaling 4,172 services with total Medicare billing of $237,203. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Advanced Heart Failure and Transplant Cardiology
- Location Los Angeles, CA
- Active Since 10/04/2006
- Last Updated 10/25/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467548073
Products in Payments
- ORGAN CARE SYSTEM (Device) $30,000
- Organ Care System (Device) $15,000
- THYMOGLOBULIN (Biological) $12,363
- THYMOGLOBULIN (Drug) $6,882
- SherpaPak (Device) $1,500
- Trifecta GT Tissue Heart Valve (Device) $113.44
- LIVTENCITY (Drug) $31.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Angeles
Dr. Thomas Magee, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Julio Gutierrez, Md, MD
Internal Medicine — Payments: $920,439
Internal Medicine $920,439
Dr. Mohammad Kamgar, M.d, M.D
Internal Medicine — Payments: $471,176
Internal Medicine $471,176
Dr. Caroline Piatek, M.d,, M.D,
Internal Medicine — Payments: $468,526
Internal Medicine $468,526
Gottfried Konecny, Md, MD
Internal Medicine — Payments: $399,651
Internal Medicine $399,651
Dr. Elizabeth Volkmann, Md, MD
Internal Medicine — Payments: $397,666
Internal Medicine $397,666